Autoantibodies and Relapse of Systemic Sclerosis After Autologous Hematopoietic Cell Transplantation
OBJECTIVE: Autologous hematopoietic cell transplantation (HCT) is an effective treatment for a subset of systemic sclerosis (SSc) patients. Unfortunately, relapse is a significant problem, with no available tests to predict relapse. We studied whether relapse is associated with…